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Abstract Several myeloid antimicrobial peptide precursors have 
been shown to consist of a N-terminal proregion similar to a 
protein named cathelin and a structurally varied C-terminal an- 
timicrobial domain. Proteins with these features have been named 
cathelicidins. In this paper we report the cDNA sequences of 
three ovine cathelicidins of 155, 160 and 190 residues, respec- 
tively, with cationic C-terminal sequences corresponding to puta- 
tive antimicrobial domains. These are structurally varied and 
include a Cys-rich sequence of 12 residues, which is similar to the 
bovine antimicrobial cyclic dodecapeptide, a novel 29 residue 
sequence named SMAP-29 with a possible a-helical conforma- 
tion, and a 60 residue sequence named Bac7.5, which appears to 
be a new member of the Pro- and Arg-rich group of mammalian 
antimicrobial peptides. 
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[1~12,14-17] and rabbit [6,30] myeloid cells. Due to the pres- 
ence of a common cathelin-like domain, these molecules have 
been named cathelicidins [31]. The antimicrobial peptides de- 
rived from cathelicidins include the Cys-rich cyclic dodecapep- 
tide [23] and protegrins [26], the Pro- and Arg-rich Bac5 and 
Bac7 [24], prophenin [27] and PR-39 [28], the Trp-rich indol- 
icidin [25] and PMAP-23 [15], the ~-helical PMAP-36 [14], 
PMAP-37 [17], CAP18(106-142) [29] and FALL-39/human 
CAP18 [18 19]. 
In order to characterize the cathelicidin family further, we 
investigated the diversity of cathelicidin mRNAs in sheep my- 
eloid cells by selectively amplifying those transcripts containing 
cathelin-like sequences. We report here the cDNA sequences 
of three ovine cathelicidins showing structurally varied C-ter- 
minal putative antimicrobial domains, which are discussed in 
relation to congeners identified in other species. 
2. Materials and methods 
1. Introduction 
Antimicrobial peptides are a widespread means of defense 
used by animals and plants against pathogens [1]. In general, 
different animal species are equipped with different arrays of 
antimicrobial peptides, which cover a broad spectrum of anti- 
microbial activity [1,2]. In mammals, several such peptides have 
been isolated from mucosal epithelia and from professional 
phagocytes [1 5]. They are synthesized as precursors (pre- 
propeptides) from which the mature peptides, which are in 
general cationic and amphipathic molecules, are released by 
proteolytic processing. 
It has recently been shown that a variety of myeloid antimi- 
crobial peptides are located C-terminal to precursors character- 
ized by a highly conserved pre-proregion [6-19]. The corre- 
sponding proforms are stored in the neutrophil granules 
[20,21]. The C-terminal region of these proforms exhibits an- 
timicrobial activity after proteolytic removal of a propiece [23 
29] which is similar to a leukocyte protein named cathelin [22]. 
The antimicrobial domains show significant diversity in size 
(12-100 residues), structure and spectrum of antimicrobial c- 
tivity. Transcripts encoding proteins with these features have 
been identified in human [18,19,21], bovine [7-9,13], porcine 
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2.1. RNA extraction and Northern analysis 
Total RNA was extracted from sheep bone marrow cells with guani- 
dinium thiocyanate [32]. Northern analysis was performed as described 
[7]. Synthetic antisense oligonucleotides 32P-labelled using standard 
protocols and derived from the 3' cDNA sequences of the ovine dode- 
capeptide (5'-CAGATCCAGTAGCTTGAGGC-3'), SMAP-29 (5'-A- 
GTTGGGCCATACTTCTTCA-3') and Bac7.5 (5'-AGTGCTAACC- 
TTGATGTT-Y), were used to hybridize Northern blots of sheep bone 
marrow total RNA. 
2.2. cDNA cloning, sequencing and sequence analysis 
The experimental conditions to obtain the 3' and 5' ends of the ovine 
dodecapeptide, SMAP-29 and Bac7.5 cDNAs were as described in [11]. 
For the 3' end amplification, sheep bone marrow mRNA was first 
reverse transcribed using the antisense primer adaptor 5'-TCGGAT- 
CCCTCGAGAAGC(T)~8-Y. The 3' ends of the three cDNAs were then 
amplified at once by PCR, using the sense oligonucleotide 5'-CGC- 
GAATTCTGTGAGCTTCAGGGTG-Y, derived from the cathelin- 
like sequence of the cathelicidin cDNAs, and the antisense primer 
adaptor 5'-TCGGATCCCTCGAGAAGCTT-3'. For each sheep 
cathelicidin, the 5' end cDNA amplification was performed by using a 
sense primer 5'-CAAGAATTCGGAGACTGGGGACCATG-Y de- 
rived from the conserved 5' untranslated sequence of previously de- 
scribed cathelicidins [7-9], and antisense primers derived from cDNA 
sequences unique to each sheep cathelicidin, amely: 5'-GACGAAT- 
TCGAAAACCCTTAGGACTC-3' (sheep dodecapeptide), 5'-AATG- 
AATTCCTACCCAGTCTTCGAA-3' (SMAP-29), and 5'-CGCGGA- 
TCCCTTCCCAATGATTATCACA-3' (Bac7.5). Amplified cDNAs 
were cloned in Bluescript KS + vector (Stratagene, San Diego, CA) and 
sequenced on both strands with deazaguanosine and automated fluo- 
rescent DNA sequencing (EMBL fluorescent DNA sequencer, Hei- 
delberg, Germany). For each different cDNA, at least 6 clones gener- 
ated from different preparations of RNA were completely sequenced 
in both directions. Sequence analysis and homology searches were 
carried out using programs from the IG suite version 5.4 (IntelliGenet- 
ics Inc.) and from the GCG suite. Secondary structure of SMAP-29 was 
predicted using the Peptidestructure (GCG) [33], the nnpredict [34] and 
the PHD network [35] prediction methods. 
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3. Results and discussion 
3.1. Cloning of sheep cathelicidin cDNAs 
We have used a molecular biological approach based on the 
high conservation of the preproregion of cathelicidins to iden- 
tify transcripts encoding molecules containing a cathelin-like 
proregion and a C-terminal putative antimicrobial domain in 
sheep myeloid cells. 
To this aim, sheep bone marrow mRNAs were amplified by 
PCR, using a sense oligonucleotide primer derived from the 
conserved prosequence of bovine [7 9] and porcine 
[10,11,14,15,17] cathelicidins, and an oligo-dT primer, so that 
the amplified products would include the 3' sequences corre- 
sponding to putative antimicrobial domains. The 3' ends of 
three different cDNAs were amplified at once by using this 
method. Northern analysis of sheep bone marrow RNA using 
antisense oligonucleotide probes derived from the unique 3' 
cDNA sequences revealed two transcipts of approximately 0.6 
kb, and one of approximately 0.9 kb (not shown). The 5' ends 
of these cDNAs were then amplified by using antisense primers 
derived from the unique 3' regions, and a sense oligonucleotide 
primer based on the conserved 5' non-coding region of previ- 
ously identified cathelicidins [7-9]. 
3.2. Features of the predicted sequences 
The three full length cDNA sequences and the deduced 
amino acid sequences, obtained from the overlapping 5' and 3' 
cDNA ends, are shown in Fig. 1. The predicted polypeptides 
show 75-81% identity in the pre-prosequences, and display the 
characteristic features of cathelicidins. These include a putative 
29 residue signal peptide and a cathelin-like prosequence of 
101-114 residues, including four invariant cysteine residues. A
putative proteolytic leavage site for elastase, commonly ob- 
served at the end of a cathelin-like domain, precedes a cationic 
C-terminal sequence of 12-60 residues. 
The 155 residue cathelicidin (Fig. 1A) has a predicted mass 
of 17649 Da and pI of 7.6. Analysis of the sequence suggests 
that this is the sheep homologue of the precursor of the bovine 
cyclic dodecapeptide [8], an antimicrobial peptide which is ac- 
tive against gram-negative and gram-positive bacteria [23]. The 
cyclic dodecapeptide is the smallest known animal antimicro- 
bial peptide and has so far been identified only in bovine neu- 
trophils. The molecule is amphipathic, with a hydrophilic re- 
gion formed by the N- and C-terminal regions brought ogether 
by a disulfide bond, and a hydrophobic region formed by resi- 
dues involved in the g turn [23]. The ovine and bovine pre- 
propeptides share 97% overall identity at the protein level, and 
alignment of the C-terminal antimicrobial domains (Fig. 2A) 
shows that the four conservative substitutions of hydrophobic 
residues in the sheep dodecapeptide o not alter the amphipa- 
thic character of the molecule. 
The 160 residue cathelicidin (Fig. 1B) has a calculated mass 
of 17813 Da and pI of 10. The 29 residue signal peptide is 
followed by a 102 residue cathelin-like domain and a 29 residue 
cationic C-terminal region with a putative amidation signal at 
the C-terminus [36]. The C-terminal sequence isunique and has 
been termed SMAP-29 from 'sheep myeloid antimicrobial pep- 
tide of 29 residues'. Sequence comparison with the other mam- 
malian antimicrobial peptides indicates that the highest level of 
identity (34%) is with the sequence of the porcine PMAP-36 
[14]. Structure prediction analysis of SMAP-29 indicates that 
A 1 AT GGAGACCCAGAGGGCCAGC CTCTCC CTGGGGCGCT GTT C GCTGTGGCT CCT GC T GCT G 
M E T Q R A S L S L G R C S L W L L L L 20 
61 GGATTAGC GCTGCCCTCGGCCAGC GC C CAGGTCCTCAGCTACAGGGAGGCCGTGCTT  G
G L A L P S A S A Q V L S Y R E A V L R 40 
t 
121 GCT GT GGAT CAGCT CAATGAGCAGT CCT CAGAACCCAACATTTAC  GTCTTCTCC~GCT G
A V D Q L N E Q S S E P N I Y R L L E L 60 
181 GACCAGC CT CCT CAGGATGATGAAGAC CCGGACAGCCC GAAGCGGGTGAGCTTCAGGGT  
D Q P P Q D D E D P D S P K R V S F R V 80 
241 AAGGAGAC GT GTGTC C CAGGAC CAC C CAGCAACCCC GGAGCAGT GTGACTT CAAGGAG 
K E T V C P R T T Q Q P P E Q C D F K E i00 
301 AAT GGGCTG CT GAAAC GGT GTGAGGGGAC~GT CAC CCTGGACCAGGTCAGGGGGAACTTC 
N G L L K R C E G T V T L D Q V R G N F 120 
361 GACATCACCTGT~TAAT CAC CAGAGCATCAGG~TACAAAGCAAC CGTGGGC~CCAC CA 
D I T C N N H Q S I R I T K Q P W A P P 140 
421 CAGGCAGCCCGAATATGT C GCATCATATTTCTAAGGGTTTGCAGATAATCAGCTCTT~TA 
Q A A R I C R I I F L R V C R * 155 
481 GATTTCT GT CACAAGCCAGC~GT CCTAAGGGTTTT CTTACTCGGCCTCAAGCTACT 
541 GGAT CT GAAAAATAAACTCTTGTGACATG ( A ) n 
1 AT GGAGAC C C A ~  CAGC~C C CTG~CGGCGTTCGCT GTC-GCTCCT GCT GCTG 
M E T Q R A S L S L G R R S L W L L L L 20 
61 GGACTAGTGCTGGCCTCGGCCA~CCAGGC CTC~ACAGC~GGCTGTGCTT C GT 
G L V L A S A R A Q A L S Y R E A V L R 40 
121 GCT GT GGATCAGCTCAATGAGAAGT C CTCAGAAGCTAATCT CTACCGCCT C CT GG~TA 
A V D Q L N E K S S E A N L Y R L L E L 60 
181 GAC C C GCCT C C CAAGCAGGATGACGAGAACT AAACAT C C C GAAGCCTGTGAGCTT ~ 
D P P P K Q D D E N S N I P K P V S F R 80 
241 GT GAAGGAGACC GT GT GC CC CAGGAC GAG C CAGCAGCCCGC GGAGCAGTGT GACTT CAAG 
v K E T V C P R T S Q Q P A E Q C D F K i00 
301 GAGAAT GGGCTGCTGAAAGAGTGTGTGGGGAC~GTCACCTTGGACCAGGTCGGGAATAAC 
E N G L L K E C V G T V T L D Q V G N N 120 
361 TT C GACAT CACCT GT GCT GAGCCCCAGAGT GTCAG~CTT C GAAGACTGGGTAGGAAG 
F D I T C A E P Q S V R G L R R L G R K 140 
421 ATAGCACAT GGTGTGAAGAAGTATGGCCCAACT G T CTCCGAATP~AT CAGAATAC.CTGGG 
I A H G V K K Y G P T v L R I I R I A G 160 
481 TGAATT GT GGGCCCAGGAAAGAGT C CTAAGGGTCT GCCAGCCCT GGTGAAGACTT CT GGA 









ATGGAGACCCAGATGGCCAGCCCCTCGCTGGGACGGT GTTCGCT GTGGCTCCTGCTGCTG 
M E T Q M A S P S L G R C S L W L L L L 20 
GGACTATTGCTGCCCTCGGCCAGCGCCCAGGCC CT AGCTACAGGG~GGCCGTGCTTCGT 
G L L L P S A S A $Q A L S Y R E A V L R 40 
GCT GT GGGTCAGCTCAAT GAGAAATC CT CAGAAGTTAAT CTCTAC C GC CT C CT GGAG C TA 
A V G Q L N E K S S E V N L Y R L L E L 60 
GACCCGCCTCCCAAGGATGCGGAGGACCAGGGAGCTCGAAAGCCTGTGAGCTTCAGGGTG 
D P P P K D A E D Q G A R K P V S F R V 80 
AAGGAGAC T GT GT GCC C CAGGAT GAGC CAGCAG C C CC C GGAGCAGT GT GACTT CAAGC.AG 
K E T V C P R M S Q Q P P E Q C D F K E i00 
AAT GGGCT GGTGAAACAGT GT GT G GGGACAGTCAGC T GGACAC GTC CAAT GAT GAGTTT 
N G L V K Q C V G T V S L D T S N D E F 120 
GAC CTAAAC TGT~.Z~T GAGCT TCAGAGT GT GAGGAGACT CGCCC CC GGC GCC CAC GTT T G 
D L N C N E L Q S V R R L R P R R P R L 14~ 
C CAAGGCCAAGGCCAAGGCCAAGGC CAAGGC CAAGGT CATT GC CAT TAC CAC GGC CACAG 
P R P R P R P R P R P R S L P L P R P Q 160 
481 C C GAGGCGAAT  C CAAGGCCAATAC TATTAC C TT G GC GAC CT C CAAGGCCAATTC AAGG 
P R R I P R P I L L P W R P P R P I P R 180 
541 C CACAC-C CACAGCCAATT CCAAGGT G GTT GT GATAATCATT GGGAAGGC AACATCAAGG 
P Q P Q P I P R W L * 190 
601 T TAGCAC T GC GGC CAAGAC CAG C GCC GAGC C CACAT C CATT C TT GCT GACAT CT C C CATT 
661 C CAAG GTTT C CT GGAAAACAGC GAAGGATTGG T GACAT CACACC CATTAAAGAATTT T G 
721 ATGAATCCTGAGTCCACAGAAGGGTCCTAAGGGTTTGACTTGTTTGCCTAGACTTCT GGA 
781 C GGTGAAAAATAAATTCT GGTGAAGAC (A ) n 
Fig. 1. Nucleotide and deduced amino acid sequences ofthe precursors 
of the sheep cyclic dodecapeptide (A), SMAP-29 (B) and Bac7.5 (C). 
The nucleotide sequences are numbered from the left, the amino acid 
sequences are numbered from the first methionine on the right. The 
arrows show the respective putative cleavage sites for signal peptidase. 
The putative antimicrobial sequences are underlined. Asterisks mark 
the stop codons. Polyadenylation signals are overlined. 
the peptide may assume a N-terminal s-helical, and a C-termi- 
nal extended conformation. Although full elucidation of the 
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A s -dodecapept ide  
b -dodecapept ide  
R ICR I IFLRVCR 
I :111 : : :1111 
RLCRIVV IRVCR 
B Bac 7.5 RRLRPRRPRLPRPRPRPRPRPRSLPLPRPQPRRIPRP ILLPWRPPRP I  ...... PRPQPQPIPRWL 
I1:111 I I I I I I I I I I  I1:111 II I I I l :  :1 I I I I  I I I  I I I I I  I 
Bac 7 RR IRPRPPRLPRPRPRP ..... .  LPFPRPGPRP I PRPLPFPRPGPRPI  PRPLPFPRPGPRP I PRPL 
Fig. 2. Alignment of the sheep dodecapeptide (s-dodecapeptide) with the bovine dodecapeptide (b-dodecapeptide) (A),and of Bac7.5 with the bovine 
Bac7 (B). The amino acid sequences of s-dodecapeptide and of Bac7.5 are deduced from cDNA. The sequence ofb-dodecapeptide s from [8,23], 
the sequence ofBac7 is from [13,37]. :, indicates identical residues; :, indicates similar esidues. Gaps are indicated by dots. 
structure of SMAP-29 requires tructural analysis of the pep- 
tide, it is nonetheless worth noting that a helical wheel projec- 
tion of the N-terminal region encompassing residues 1-18 (Fig. 
3) would result in an ~-helix with a clearcut amphipathic ar- 
rangement typical of membrane-perturbing agents. The helix 
would be characterized by the symmetric placing of Gly resi- 
dues at the interface between polar and hydrophobic regions. 
The presence of Gly and Pro at positions 18 and 19 suggests 
a loop/turn at this point. 
The 190 residue cathelicidin (Fig. 1C) has a calculated mass 
of 21831 Da and pI of 11.7, and shows a Pro- and Arg-rich 
C-terminal domain of 60 residues following a 29 residue signal 
peptide and a 101 residue cathelin-like prosequence. This pro- 
tein is 85% identical to the precursor of the bovine Bac7 [13], 
a 60 residue antimicrobial peptide characterized by a highly 
repetitive Pro- and Arg-rich sequence [37]. Comparison of the 
nucleotide sequences (not shown) shows 90% identity in the 5' 
pre-proregions (nt 1-390), 83% with a two gap insertion in the 
sequences corresponding to the antimicrobial domain (nt 391- 
570) and 93% in the 3' non-coding regions (nt 571-807). The 
high level of identity suggests that the ovine and bovine precur- 
sors are derived from a common ancestor gene, from which the 
precursor of porcine PR-39 [10,38] may also have originated. 
Also, a decreased nucleotide identity in the region encompass- 
ing nt 391 570 indicates that the rate of mutation in the se- 
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Fig. 3. Helical wheel projection of SMAP-29(l-18). Charged residues 
are shown in bold and hydrophobic residues are in italics. 
quence corresponding to the antimicrobial domain is higher 
than in the remaining parts of the molecule. In fact, a fast 
evolving antimicrobial domain is a feature common to other 
genes encoding defense peptides [1] and appears to be an impor- 
tant requisite for molecules that have to keep up with highly 
variable and rapidly changing pathogens. Compared to bovine 
Bac7, the putative ovine antimicrobial peptide, which has been 
termed Bac7.5 based on the mol wt, shows a higher content of 
Arg (33% versus 28%) and a lower content of Pro (38% versus 
45%). The two sequences (Fig. 2B) show a short stretch of 
similar residues at the N-terminus, most of them in common 
to the sequence of PR-39 [10,28]. This region is followed in the 
sequence of Bac7 by three tandemly repeated tetradecamers 
which are not present in the sequence of Bac7.5, although short 
regions of similarity, including several PRP repeats, can be 
noted. PRP repeats, and other proline-rich repeats are often 
observed in the Pro-and Arg-rich antimicrobial peptides 
[27,28,37] and are likely to influence their structure. Recent 
studies indicate that this type of peptide may adopt conforma- 
tions similar to the polyproline type II helix [39~10]. Consider- 
ing the sequences of the ovine Bac7.5 and the bovine Bac7 from 
an evolutionary point of view, it may be speculated that dupli- 
cation of the tetradecamer in Bac7 occurred after the two spe- 
cies diverged, in view of the nearly complete conservation f the 
three repeats at the nucleotide l vel [13]. Further evolutionary 
changes likely contributed tothe structural diversity of the two 
sequences, in addition to the duplication event, and analysis at 
the gene level will help understand the genetic mechanisms 
which promoted these changes. Furthermore, it is becoming 
apparent that a study of the homology of the cathelicidin pre- 
proregions within a species and among species may provide 
valuable information on evolutionary elationships. Thus, it is 
also important that a large number of sequences be collected 
from several species. 
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